Publications
5674 Results
- Journal / Conference
- Journal of Thoracic Oncology Jul;10(7):1099-1106
- Year
- 2015
- Research Committee(s)
- Lung
- PMID
- PMID26134227
- PMC
- PMC4493926
- Study Number(s)
- S0124
Multitrial evaluation of progression-free survival as a surrogate end point for overall survival in first-line extensive-stage small-cell lung cancer
- Journal / Conference
- Journal of Thoracic Oncology 2015 May;10(5):e36
- Year
- 2015
- Research Committee(s)
- Lung
- PMID
- PMID25898968
- PMC
- letter to editor not within scope of Public Access Policy
- Study Number(s)
- S0327, S0435, S0802
Reply to "diminishing role of platinum-sensitivity status in patients with small cell lung cancer"
- Journal / Conference
- Clinical Cancer Research 21(18):4048-4054
- Year
- 2015
- Research Committee(s)
- Genitourinary
- PMID
- PMID25967143
- PMC
- PMC4573791
- Study Number(s)
- CTSU/E2805
Effects of adjuvant sorafenib and sunitinib on cardiac function in renal cell carcinoma patients without overt metastases: results from ASSURE, ECOG 2805
- Journal / Conference
- Blood 126(23):908; American Society of Hematology Annual Meeting (Dec 5-8, 2015, Orlando, FL), oral;
- Year
- 2015
- Research Committee(s)
- Leukemia
- Study Number(s)
- S1117
Additional analyses of a randomized phase II study of azacitidine combined with lenalidomide or with vorinostat vs. azacitidine monotherapy in higher-risk myelodysplastic syndromes (MDS) and chronic myelomonocytic leukemia (CMML): North American Intergroup Study SWOG S1117
- Journal / Conference
- American College of Surgeons Bulletin Dec;100(12):49-50
- Year
- 2015
- Research Committee(s)
- Palliative Care
- PMID
- PMID26749971
- Study Number(s)
- S1316
Prospective comparative effectiveness trial for malignant bowel obstruction: SWOG S1316
- Journal / Conference
- Seminars in Oncology, Oct;42(5):679-680
- Year
- 2015
- Research Committee(s)
- Cancer Care Delivery
- PMID
- PMID26433548
Progress and infrastructure for improved patient outcomes of the National Cancer Institute Network Groups [Introduction to Issue, "The NCI Network Groups"]
- Journal / Conference
- Journal of Thoracic Oncology 10(9): S141 (Suppl 2, MTE 02); World Conference on Lung Cancer (WCLC), oral;
- Year
- 2015
- Research Committee(s)
- Lung
- Study Number(s)
- S1400
Patients, investigators and pharmaceuticals working together to accelerate research and access: the lung cancer master protocol (Lung-MAP) clinical trial
- Journal / Conference
- Journal of Thoracic Oncology 10(9):S80 (Suppl 2, abst ED07.03); World Conference on Lung Cancer (WCLC) (September 6-9, 2015, Denver, CO), oral;
- Year
- 2015
- Research Committee(s)
- Lung
- Study Number(s)
- S1400
Lung master protocol in squamous cell lung Cancer (Lung-MAP, S1400)
- Journal / Conference
- Blood 126(23):6;American Society of Hematology Annual Meeting (Dec 5-8, 2015, Orlando, FL), oral;
- Year
- 2015
- Research Committee(s)
- Leukemia
- Study Number(s)
- CTSU/C10603
The multi-kinase inhibitor midostaurin (M) prolongs survival compared with placebo (P) in combination with daunorubicin (D)/cytarabine (C) induction (ind), high-dose C consolidation (consol), and as maintenance (maint) therapy in newly diagnosed acute myeloid leukemia (AML) patients (pts) age 18-60 with FLT3 mutations (muts): an international prospective randomized (rand) P-controlled double-blind trial (CALGB 10603/RATIFY [Alliance])
- Journal / Conference
- Chinese Clinical Oncology Sep;4(3):36
- Year
- 2015
- Research Committee(s)
- Lung
- PMID
- PMID26408303
- PMC
- PMCID n/a
- Study Number(s)
- S1400